Skip to main content
Premium Trial:

Request an Annual Quote

Lonza 4D-Nucleofector Platform

Lonza has launched its next generation 4D-Nucleofector platform for non-viral transfection of a variety of cell types, particularly difficult-to-transfect cells such as immune cells. The Nucleofector technology uses an advanced electroporation approach to target cell nuclei directly. The 4D-Nucleofector Core Unit can operate up to three functional modules, enabling tailored experimental setups and low- to high-volume transfections. A fully integrated 96-well unit is ideal for users with mid-scale transfection requirements, while an 8-inch touchscreen display enables users to easily set up their experiments and control all functional modules. Optimized protocols are available for more than 750 different cell types, Lonza noted.